In this article, we describe the role of bone-targeted therapies, specifically for managing early breast cancer, by reviewing their bone-specific and cancer-specific benefits.
Jacques Raphael, MD, MSc, FRCPC
Advertisement
Articles by Jacques Raphael, MD, MSc, FRCPC
Advertisement
Latest Updated Articles
Bone-Targeted Therapy in Early Breast CancerPublished: November 15th 2018 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Subcutaneous Amivantamab in EGFR+ NSCLC
2
Imlunestrant Combo Will Not Be Pursued for FDA Approval in Breast Cancer
3
FDA Grants Regular Approval to Rucaparib in Metastatic CRPC
4
Gathering Data to Ascertain Biomarker Specificity in HER2– Breast Cancer
5